SymBio Pharmaceuticals
4582.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 48.93% |
| Cantor Fitzgerald Europe | 7.35% |
| YOSHIDA FUMINORI | 6.35% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 2
| Heights Capital Management, Inc. | 4.18% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 74
| Holder | Ratio | Change |
|---|---|---|
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 39.09% | -1.48pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 40.57% | -1.15pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 41.72% | +1.39pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 40.33% | -1.86pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 42.19% | -2.22pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 44.41% | -1.02pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 45.43% | -1.13pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 46.56% | -1.15pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 47.71% | -0.96pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 48.67% | -1.11pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.